Division of Cardiology, Children’s National Medical Center, Washington, DC, USA.
Haematologica. 2012 Feb;97(2):193-200. doi: 10.3324/haematol.2011.051839. Epub 2011 Oct 11.
Patients with Chuvash polycythemia, (homozygosity for the R200W mutation in the von Hippel Lindau gene (VHL)), have elevated levels of hypoxia inducible factors HIF-1 and HIF-2, often become iron-deficient secondary to phlebotomy, and have elevated estimated pulmonary artery pressure by echocardiography. The objectives of this study were to provide a comprehensive echocardiographic assessment of cardiovascular physiology and to identify clinical, hematologic and cardiovascular risk factors for elevation of tricuspid regurgitation velocity in children and adults with Chuvash polycythemia.
This cross-sectional observational study of 120 adult and pediatric VHL(R200W) homozygotes and 31 controls at outpatient facilities in Chuvashia, Russian Federation included echocardiography assessment of pulmonary artery pressure (tricuspid regurgitation velocity), cardiac volume, and systolic and diastolic function, as well as hematologic and clinical parameters. We determined the prevalence and risk factors for elevation of tricuspid regurgitation velocity in this population and its relationship to phlebotomy.
The age-adjusted mean ± SE tricuspid regurgitation velocity was higher in VHL(R200W) homozygotes than controls with normal VHL alleles (2.5±0.03 vs. 2.3±0.05 m/sec, P=0.005). The age-adjusted left ventricular diastolic diameter (4.8±0.05 vs. 4.5±0.09 cm, P=0.005) and left atrial diameter (3.4±0.04 vs. 3.2±0.08 cm, P=0.011) were also greater in the VHL(R200W) homozygotes, consistent with increased blood volume, but the elevation in tricuspid regurgitation velocity persisted after adjustment for these variables. Among VHL(R200W) homozygotes, phlebotomy therapy was associated with lower serum ferritin concentration, and low ferritin independently predicted higher tricuspid regurgitation velocity (standardized beta=0.29; P=0.009).
Children and adults with Chuvash polycythemia have higher estimated right ventricular systolic pressure, even after adjustment for echocardiography estimates of blood volume. Lower ferritin concentration, which is associated with phlebotomy, independently predicts higher tricuspid regurgitation velocity (www.clinicaltrials.gov identifier NCT00495638).
楚瓦什红细胞增多症患者(纯合子携带 von Hippel Lindau 基因(VHL)中的 R200W 突变),缺氧诱导因子 HIF-1 和 HIF-2 水平升高,由于放血疗法经常导致缺铁,并且通过超声心动图检测到肺动脉压升高。本研究的目的是提供对心血管生理学的全面超声心动图评估,并确定儿童和成人楚瓦什红细胞增多症患者三尖瓣反流速度升高的临床、血液学和心血管危险因素。
这项在俄罗斯楚瓦什共和国门诊设施进行的 120 名成年和儿科 VHL(R200W)纯合子和 31 名对照的横断面观察性研究包括超声心动图评估肺动脉压(三尖瓣反流速度)、心腔容量以及收缩和舒张功能,以及血液学和临床参数。我们确定了该人群中三尖瓣反流速度升高的患病率和危险因素及其与放血疗法的关系。
调整年龄后的平均±SE 三尖瓣反流速度在 VHL(R200W)纯合子中高于正常 VHL 等位基因对照(2.5±0.03 与 2.3±0.05 m/sec,P=0.005)。调整年龄后的左心室舒张直径(4.8±0.05 与 4.5±0.09 cm,P=0.005)和左心房直径(3.4±0.04 与 3.2±0.08 cm,P=0.011)也更大VHL(R200W)纯合子,这与血容量增加一致,但在调整这些变量后,三尖瓣反流速度的升高仍然存在。在 VHL(R200W)纯合子中,放血疗法与血清铁蛋白浓度降低相关,而低铁蛋白独立预测三尖瓣反流速度更高(标准化β=0.29;P=0.009)。
即使调整了超声心动图估计的血容量,楚瓦什红细胞增多症的儿童和成人的右心室收缩压也较高。较低的铁蛋白浓度(与放血疗法相关)独立预测三尖瓣反流速度更高(www.clinicaltrials.gov 标识符 NCT00495638)。